The results showed that tumor area IL-23 expression did not correlate to patients' age, gender, cirrhosis status, TNM stage and tumor size, while tumor area IL-23 (p19 and p40) expression was significantly correlated to patients' metastasis status (Table 1). This evidence concerns the gene IL37 and Cirrhosis.